Biodesix Inc

NASDAQ:BDSX   3:57:48 PM EDT
1.62
+0.03 (+1.89%)
Earnings Announcements

Biodesix Announces First Quarter 2022 Results And Highlights

Published: 05/11/2022 10:08 GMT
Biodesix Inc (BDSX) - Biodesix Announces First Quarter 2022 Results and Highlights.
Biodesix Inc - Q1 2022 Core Lung Diagnostic Revenue of $4.6 Million Increased 17% Over Comparable Period in 2021.
Biodesix Inc - Reaffirms Our 2022 Financial Outlook.
Biodesix Inc - Qtrly Loss per Share $0.50.
Revenue is expected to be $8.83 Million
Adjusted EPS is expected to be -$0.42

Next Quarter Revenue Guidance is expected to be $10.68 Million
Next Quarter EPS Guidance is expected to be -$0.32

More details on our Analysts Page.